SeaCrest Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History

SeaCrest Wealth Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,949	Closed	-$369K	–	696
2021 Q1	$369K	Buy	+1,949	New	+$328K	0.05%	405
2019 Q2	–	Sell	-25	Closed	-$7K	–	845
2019 Q1	$7K	Hold	25	–	–	﹤0.01%	1620
2018 Q4	$2K	Sell	25 -25	-50%	-$3.41K	﹤0.01%	1899
2018 Q3	$10K	Sell	50 -13	-21%	-$2.74K	﹤0.01%	1647
2018 Q2	$14K	Buy	+63	New	+$14.2K	﹤0.01%	1487

Other funds holding DNTH

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return